DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Cantini F, Niccoli L, Goletti D.
Tuberculosis risk in patients treated with non-anti-tumor necrosis factor-alpha (TNF-alpha) targeted biologics and recently licensed TNF-alpha inhibitors: data from clinical trials and national registries.
J Rheumatol Suppl 2014;
91: 56-64
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.